A recent case‐study further supporting the association of adaptive immunity and T‐cells in delayed DILI reactions is atabecestat (a BACE inhibitor developed for the treatment of Alzheimer's disease, but terminated due to liver enzyme elevations in some patients48). Here, BACE1 is linked to Alzheimer disease.